New-onset myasthenia gravis after mRNA SARS-CoV-2 vaccination: a case series

BACKGROUND: Myasthenia gravis (MG) is an autoimmune disease that targets acetylcholine receptor (AChR) of the neuromuscular junction. New-onset MG after SARS-CoV-2 vaccination has rarely been reported. CASE PRESENTATION: We report about three patients who presented new-onset myasthenia gravis after...

Descripción completa

Detalles Bibliográficos
Autores principales: Fanella, Gaia, Baiata, Claudio, Candeloro, Elisa, Toscano, Gianpaolo, Colnaghi, Silvia, Mauri, Marco, Cariddi, Lucia Princiotta, Rebecchi, Valentina, Solazzo, Francesca, Banfi, Paola, Piatti, Marialuisa, Ferrarese, Carlo, Versino, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Covid-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308404/
https://www.ncbi.nlm.nih.gov/pubmed/35870026
http://dx.doi.org/10.1007/s10072-022-06284-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308404/
https://www.ncbi.nlm.nih.gov/pubmed/35870026
http://dx.doi.org/10.1007/s10072-022-06284-5

Ejemplares similares